Chest CT-assessed comorbidities and all-cause mortality risk in COPD patients in the BODE cohort.
Chest CT-assessed comorbidities and all-cause mortality risk in COPD patients in the BODE cohort.
复制标题
DOI:
10.1111/resp.14223
复制
发表时间:
2022-04
期刊:
影响因子:
--
通讯作者:
de Torres JP
中科院分区:
文献类型:
--
作者:
Ezponda A;Casanova C;Divo M;Marín-Oto M;Cabrera C;Marín JM;Bastarrika G;Pinto-Plata V;Martin-Palmero Á;Polverino F;Celli BR;de Torres JP
The availability of chest computed tomography (CT) imaging can help diagnose comorbidities associated with chronic obstructive pulmonary disease (COPD). Their systematic identification and relationship with all‐cause mortality have not been explored. Furthermore, whether their CT‐detected prevalence differs from clinical diagnosis is unknown. The prevalence of 10 CT‐assessed comorbidities was retrospectively determined at baseline in 379 patients (71% men) with mild to severe COPD attending pulmonary clinics. Anthropometrics, smoking history, dyspnoea, lung function, exercise capacity, BODE (BMI, Obstruction, Dyspnoea and Exercise capacity) index and exacerbations rate were recorded. The prevalence of CT‐determined comorbidities was compared with that recorded clinically. Over a median of 78 months of observation, the independent association with all‐cause mortality was analysed. A ‘CT‐comorbidome’ graphically expressed the strength of their association with mortality risk. Coronary artery calcification, emphysema and bronchiectasis were the most prevalent comorbidities (79.8%, 62.7% and 33.9%, respectively). All were underdiagnosed before CT. Coronary artery calcium (hazard ratio [HR] 2.09; 95% CI 1.03–4.26, p = 0.042), bronchiectasis (HR 2.12; 95% CI 1.05–4.26, p = 0.036) and low psoas muscle density (HR 2.61; 95% CI 1.23–5.57, p = 0.010) were independently associated with all‐cause mortality and helped define the ‘CT‐comorbidome’. This study of COPD patients shows that systematic detection of 10 CT‐diagnosed comorbidities, most of which were not detected clinically, provides information of potential use to patients and clinicians caring for them. This multicentric study shows that chest computed tomography (CT) to evaluate the presence of 10 comorbidities detects important pathologies not diagnosed in the clinical management of those patients. While emphysema, coronary artery calcification (CAC) and bronchiectasis were the most prevalent CT‐detected comorbidities, CAC, bronchiectasis and low Psoas muscle density were independently associated with all‐cause mortality. See related Editorial
登录
查看更多内容
影响因子:
8
作者:
de la Rosa Carrillo, David;Luis Lopez-Campos, Jose;Asesor del Documento, Comite
通讯作者:
Asesor del Documento, Comite
影响因子:
2.3
作者:
Ascha M;Renapurkar RD;Tonelli AR
通讯作者:
Tonelli AR
影响因子:
5.8
作者:
Agusti A;Calverley PM;Celli B;Coxson HO;Edwards LD;Lomas DA;MacNee W;Miller BE;Rennard S;Silverman EK;Tal-Singer R;Wouters E;Yates JC;Vestbo J;Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators
通讯作者:
Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators
影响因子:
5.8
作者:
Hersh CP;Washko GR;Estépar RS;Lutz S;Friedman PJ;Han MK;Hokanson JE;Judy PF;Lynch DA;Make BJ;Marchetti N;Newell JD Jr;Sciurba FC;Crapo JD;Silverman EK;COPDGene Investigators
通讯作者:
COPDGene Investigators
影响因子:
24.3
作者:
Celli, Bartolome R.;Locantore, Nicholas;Agusti, Alvar
通讯作者:
Agusti, Alvar